DM programs take advantage of new therapies to reduce costs, complications for MS patients

Multiple sclerosis patients can benefit from new drugs that slow the progression of the disease, but only a fraction (20%) actually receive these drugs. A specialty DM firm has found a way to enhance medication management and assist patients in keeping debilitating complications at bay.